Leader mondiale nella gestione dei fluidi

  • Il Sistema per ultrafiltrazione gentile Aquadex SmartFlow® è specificamente progettato per eliminare l’acqua in eccesso nei pazienti con sovraccarico di liquidi e in grado di ripristinare l’efficacia del diuretico.
  • Il Sistema Aquadex SmartFlow® è clinicamente testato, sicuro, efficace e migliora la qualità della vita dei pazienti.
  • Questo sistema è unico e brevettato, con marchio FDA e CE.

Aquadex Smartflow

Guida rapida alla terapia 

Scarica la guida rapida

Business Overview 

Scarica la Business Overview

Approfondimento dedicato ad Aquadex SmartFlow


Evidenze Cliniche

Study Name Study Design # of Patients Study Patient Group Date Key Findings
SAFE Multi-center, prospective, single arm 21 IDE for 510k 2003 JCF Extracellular and intravascular fluid volume excess can be safely achieved via peripherally inserted UF
Fluid removal endpoint achieved in 92% of patients
RAPID-HF Multi-center, prospective, RCT 40
20 UF/20 SC		 Early UF vs Diuretics 2005 JACC Early use of UF in CHF patients resulted in weight loss and significant fluid removal
Dyspnea and CHF symptoms were significantly improved in the UF group at 48 hours
EUPHORIA Single-center, prospective, single-arm 20 Early UF in diuretic resistance 2005 JACC Early UF before IV diuretics may decrease length of stay and readmission
Average length of stay was 3.7 days
60% of patients were discharged in ≤ 3 days
UNLOAD Multi-center, prospective, RCT 200
100 UF/100 SC		 UF vs SC 2007 JACC At 48 hours, weight and net fluid loss were greater in the UF group than IV diuretics
At 90-days, UF group had fewer patients rehospitalized for heart failure, heart failure rehospitalization days per patient, and unscheduled visits than IV diuretics
CARRESS-HF Multi-center, prospective, RCT 188
94 UF/94 SC		 UF vs SC patients with cardiorenal syndrome 2012 NEJM Stepped pharmacological therapy algorithm was superior to a strategy of ultrafiltration for the preservation of renal function at 96 hours, with a similar amount of weight loss with the two approaches
AVOID-HF Multi-center, prospective, RCT 224
110 UF/114 SC (810 planned)		 UF vs SC to evaluate readmissions 2016 JACC-HF Ultrafiltration group trended towards a longer time to first HF event within 90 days and fewer HF and cardiovascular events

UF = Ultrafiltration

Pubblicazioni sull’ultrafiltrazione gentile con Aquadex SmartFlow

Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research

2017 | Costanzo et al. | Journal of the American College of Cardiology
Approfondisci

Readmission Rate After Ultrafiltration in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis

2017 | Siddiqui et al. | Heart Failure Reviews

Approfondisci

Optimizing the Delivery of Ultrafiltration in Critically Ill Patients

2020 | Frederic Michard, MD, PhD | MiCo Sàrl by michardconsulting.com
Approfondisci

Defining The Role of Ultrafiltration Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

2016 | Jain et al. | Heart Failure Reviews
Approfondisci

Efficacy and safety assessment of isolated ultrafiltration compared to intravenous diuretics for acutely decompensated heart failure: a systematic review with meta-analysis

2014 | De Vecchis et al. | Minerva Cardioangiol
Approfondisci

Perchè www.medstep.it? Per aiutare chi ha scelto di dotarsi del dispositivo Medstep

L’ambizione di questo sito è rassicurare chi compra un apparecchio nell’aver scelto un prodotto di qualità, nel poter scegliere quelli ritenuti sicuri e affidabili dal mercato attraverso certificazioni internazionali che lo attestino (FDA ente notificatore americano) e nel pagarlo al giusto prezzo.

Supporto clienti

Compila il form sottostante indicando le tue curiosità e necessità per essere contattato dallo staff di Medstep, oppure chiama il numero verde: 800 144 357